

Granite Bio Innovation
62 posts

@GraniteBio
Advancing human flourishing in New Hampshire and America by promoting ethical, emerging biotechnology in the Granite State.
















New Hampshire’s Right to Try bills, HB 1734 and HB 1735, faced a setback today when the Senate HHS Committee voted against both bills. These bills will make NH the best state in America for emerging therapies—drawing on successful laws already passed in Montana and other states. While both Senate Democrats opposed the bills, Republicans on the committee were divided—with GOP Senators Regina Birdsell and Dan Innis both indicating they were prepared to support the bills. We remain optimistic. These bills earned the votes of every single Republican and some Democrats in the New Hampshire House. Elected leaders know that these bills will help patients and expand the New Hampshire Advantage. We believe both bills will pass this month—we’ll just have to take the long way to get there. Learn more and take action below.

New Hampshire’s Right to Try bills, HB 1734 and HB 1735, faced a setback today when the Senate HHS Committee voted against both bills. These bills will make NH the best state in America for emerging therapies—drawing on successful laws already passed in Montana and other states. While both Senate Democrats opposed the bills, Republicans on the committee were divided—with GOP Senators Regina Birdsell and Dan Innis both indicating they were prepared to support the bills. We remain optimistic. These bills earned the votes of every single Republican and some Democrats in the New Hampshire House. Elected leaders know that these bills will help patients and expand the New Hampshire Advantage. We believe both bills will pass this month—we’ll just have to take the long way to get there. Learn more and take action below.


“When we pass these bills, New Hampshire will be - on every level - the best jurisdiction for experimental biotech in America. Biotech innovation is a key part of the Granite State advantage and the bright future we are building in New Hampshire.” -@IanHuyett


"There is currently a flurry of interest among experimental biotech companies in New Hampshire as a potential innovation hub." -@TeamEricaNH in @UnionLeader today in support of HB 1734 and HB 1735

"There is currently a flurry of interest among experimental biotech companies in New Hampshire as a potential innovation hub." -@TeamEricaNH in @UnionLeader today in support of HB 1734 and HB 1735




He was diagnosed with bone cancer. He went through surgery, radiation, chemo. Then it stopped working. No treatments left. No viable trials. That’s where most stories end. He found a way to access an experimental drug anyway.
